Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847560 · ClinicalTrials.gov registry record
Anticoagulant Utilization Pattern
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 333,664
- Enrollment target
NCT01847560 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 333,664 participants.
The verdict
NCT01847560 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 333,664 participants
- Enrollment target
Study Summary
This study plans to describe utilization patterns for oral anticoagulants over time in patients with non-valvular atrial fibrillation at risk for stroke using electronic claims data from a United States commercial insurance database.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333,664 participants |
| Start Date | 2013-04-17 |
| Est. Completion | 2017-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01847560
The ClinicalTrials.gov registry entry for NCT01847560 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 333,664 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01847560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01847560 about?
NCT01847560 is a clinical study titled "Anticoagulant Utilization Pattern". This study plans to describe utilization patterns for oral anticoagulants over time in patients with non-valvular atrial fibrillation at risk for stroke using electronic claims data from a United States commercial insurance database.
What is the current status of trial NCT01847560?
This trial is currently completed. The enrollment target is 333,664 participants. The study started on 2013-04-17. Estimated completion is 2017-11-01.
Who is sponsoring clinical trial NCT01847560?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.